Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression.
Dieleman JP, Sturkenboom MC, Wit FW, Jambroes M, Mulder JW, Ten Veen JH, Juttmann J, Stricker BH, Lange JM, Van Der Ende ME; AIDS Therapy Evaluation, The Netherlands Study Group (ATHENA). Dieleman JP, et al. Among authors: van der ende me. J Infect Dis. 2002 May 1;185(9):1261-8. doi: 10.1086/340131. Epub 2002 Apr 16. J Infect Dis. 2002. PMID: 12001043
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.
de Vries-Sluijs TE, Reijnders JG, Hansen BE, Zaaijer HL, Prins JM, Pas SD, Schutten M, Hoepelman AI, Richter C, Mulder JW, de Man RA, Janssen HL, van der Ende ME. de Vries-Sluijs TE, et al. Among authors: van der ende me. Gastroenterology. 2010 Dec;139(6):1934-41. doi: 10.1053/j.gastro.2010.08.045. Epub 2010 Aug 26. Gastroenterology. 2010. PMID: 20801123 Clinical Trial.
A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients.
de Vries-Sluijs TE, Hansen BE, van Doornum GJ, Kauffmann RH, Leyten EM, Mudrikova T, Brinkman K, den Hollander JG, Kroon FP, Janssen HL, van der Ende ME, de Man RA. de Vries-Sluijs TE, et al. Among authors: van doornum gj, van der ende me. J Infect Dis. 2011 Apr 1;203(7):984-91. doi: 10.1093/infdis/jiq137. Epub 2011 Jan 25. J Infect Dis. 2011. PMID: 21266513 Clinical Trial.
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.
Allard SD, De Keersmaecker B, de Goede AL, Verschuren EJ, Koetsveld J, Reedijk ML, Wylock C, De Bel AV, Vandeloo J, Pistoor F, Heirman C, Beyer WE, Eilers PH, Corthals J, Padmos I, Thielemans K, Osterhaus AD, Lacor P, van der Ende ME, Aerts JL, van Baalen CA, Gruters RA. Allard SD, et al. Among authors: van der ende me, van baalen ca. Clin Immunol. 2012 Mar;142(3):252-68. doi: 10.1016/j.clim.2011.10.010. Epub 2011 Nov 16. Clin Immunol. 2012. PMID: 22177848 Clinical Trial.
Current and future applications of dried blood spots in viral disease management.
Snijdewind IJ, van Kampen JJ, Fraaij PL, van der Ende ME, Osterhaus AD, Gruters RA. Snijdewind IJ, et al. Among authors: van der ende me, van kampen jj. Antiviral Res. 2012 Mar;93(3):309-21. doi: 10.1016/j.antiviral.2011.12.011. Epub 2012 Jan 5. Antiviral Res. 2012. PMID: 22244848 Review.
187 results